SCHEDER-BIESCHIN MAX 4
4 · EKSO BIONICS HOLDINGS, INC. · Filed Jun 8, 2018
Insider Transaction Report
Form 4
SCHEDER-BIESCHIN MAX
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-05-10+9,250→ 81,110 total - Tax Payment
Common Stock
2018-05-10$1.51/sh−4,151$6,248→ 76,959 total - Exercise/Conversion
Restricted Stock Units
2018-05-10−9,250→ 27,750 total→ Common Stock (9,250 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock.
- [F2]The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.